Abstract
The degeneration of cholinergic basal forebrain (cBF) neurons in Alzheimer’s disease (AD) leads to the cognitive impairment associated with this condition. cBF neurons express the p75 neurotrophin receptor (p75NTR), which mediates cell death, and the extracellular domain of p75NTR can bind to amyloid beta (Aβ) and promote its degradation. Here, we investigated the contribution of cBF neuronal p75NTR to the progression of AD by removing p75NTR from cholinergic neurons in the APP/PS1 familial AD mouse strain. Conditional loss of p75NTR slowed cognitive decline and reduced both Aβ accumulation into plaques and gliosis. Expression of the amyloid protein precursor and its cleavage enzymes ADAM10 and BACE1 were unchanged. There was also no upregulation of p75NTR in non-cholinergic cell types. This indicates that a direct interaction between cBF-expressed p75NTR and Aβ does not contribute significantly to the regulation of Aβ load. Rather, loss of p75NTR from cBF neurons, which results in increased cholinergic innervation of the cortex, appears to regulate alternative, more dominant, Aβ clearance mechanisms.
Similar content being viewed by others
References
Whitehouse PJ, Struble RG, Clark AW, Price DL (1982) Alzheimer disease: plaques, tangles, and the basal forebrain. Ann Neurol 12(5):494. https://doi.org/10.1002/ana.410120517
Grothe MJ, Schuster C, Bauer F, Heinsen H, Prudlo J, Teipel SJ (2014) Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer’s disease dementia. J Neurol 261(10):1939–1948. https://doi.org/10.1007/s00415-014-7439-z
Grothe M, Heinsen H, Teipel S (2013) Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer’s disease. Neurobiol Aging 34(4):1210–1220. https://doi.org/10.1016/j.neurobiolaging.2012.10.018
Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, Bennett DA, Jaffar S et al (2002) Loss of basal forebrain p75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer’s disease. J Comp Neurol 443(2):136–153
Schmitz TW, Nathan Spreng R, Alzheimer’s Disease Neuroimaging I (2016) Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology. Nat Commun 7:13249. https://doi.org/10.1038/ncomms13249
Grothe M, Zaborszky L, Atienza M, Gil-Neciga E, Rodriguez-Romero R, Teipel SJ, Amunts K, Suarez-Gonzalez A et al (2010) Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer’s disease. Cereb Cortex 20(7):1685–1695. https://doi.org/10.1093/cercor/bhp232
Grothe MJ, Ewers M, Krause B, Heinsen H, Teipel SJ, Alzheimer's Disease Neuroimaging I (2014) Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects. Alzheimers Dement 10(5 Suppl):S344–S353. https://doi.org/10.1016/j.jalz.2013.09.011
Teipel S, Heinsen H, Amaro E Jr, Grinberg LT, Krause B, Grothe M, Alzheimer's Disease Neuroimaging I (2014) Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer’s disease. Neurobiol Aging 35(3):482–491. https://doi.org/10.1016/j.neurobiolaging.2013.09.029
Teipel SJ, Meindl T, Grinberg L, Grothe M, Cantero JL, Reiser MF, Moller HJ, Heinsen H et al (2011) The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study. Hum Brain Mapp 32(9):1349–1362. https://doi.org/10.1002/hbm.21111
Kerbler GM, Fripp J, Rowe CC, Villemagne VL, Salvado O, Rose S, Coulson EJ, Alzheimer’s Disease Neuroimaging I (2015) Basal forebrain atrophy correlates with amyloid β burden in Alzheimer’s disease. NeuroImage Clin 7:105–113. https://doi.org/10.1016/j.nicl.2014.11.015
Kerbler GM, Nedelska Z, Fripp J, Laczo J, Vyhnalek M, Lisy J, Hamlin AS, Rose S et al (2015) Basal forebrain atrophy contributes to allocentric navigation impairment in Alzheimer’s disease patients. Front Aging Neurosci 7:185. https://doi.org/10.3389/fnagi.2015.00185
Laursen B, Mork A, Plath N, Kristiansen U, Bastlund JF (2013) Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice. Behav Brain Res 240:146–152. https://doi.org/10.1016/j.bbr.2012.11.012
Gil-Bea FJ, Gerenu G, Aisa B, Kirazov LP, Schliebs R, Ramirez MJ (2012) Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice. Neurobiol Dis 48(3):439–446. https://doi.org/10.1016/j.nbd.2012.06.020
Hartig W, Saul A, Kacza J, Grosche J, Goldhammer S, Michalski D, Wirths O (2014) Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice. Neuropathol Appl Neurobiol 40(2):106–120. https://doi.org/10.1111/nan.12050
Ramos-Rodriguez JJ, Pacheco-Herrero M, Thyssen D, Murillo-Carretero MI, Berrocoso E, Spires-Jones TL, Bacskai BJ, Garcia-Alloza M (2013) Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice. J Neuropathol Exp Neurol 72(4):272–285. https://doi.org/10.1097/NEN.0b013e318288a8dd
Turnbull MT, Boskovic Z, Coulson EJ (2018) Acute down-regulation of BDNF signaling does not replicate exacerbated amyloid-β levels and cognitive impairment induced by cholinergic basal forebrain lesion. Front Mol Neurosci 11:51. https://doi.org/10.3389/fnmol.2018.00051
Hernandez CM, Kayed R, Zheng H, Sweatt JD, Dineley KT (2010) Loss of α7 nicotinic receptors enhances β-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer’s disease. J Neurosci 30(7):2442–2453. https://doi.org/10.1523/JNEUROSCI.5038-09.2010
Sotthibundhu A, Sykes AM, Fox B, Underwood CK, Thangnipon W, Coulson EJ (2008) β-amyloid1-42 induces neuronal death through the p75 neurotrophin receptor. J Neurosci 28(15):3941–3946
Knowles JK, Simmons DA, Nguyen TV, Vander Griend L, Xie Y, Zhang H, Yang T, Pollak J et al (2013) A small molecule p75 ligand prevents cognitive deficits and neurite degeneration in an Alzheimer’s mouse model. Neurobiol Aging 34:2052–2063. https://doi.org/10.1016/j.neurobiolaging.2013.02.015
Knowles JK, Rajadas J, Nguyen TV, Yang T, LeMieux MC, Vander Griend L, Ishikawa C, Massa SM et al (2009) The p75 neurotrophin receptor promotes amyloid-β1-42-induced neuritic dystrophy in vitro and in vivo. J Neurosci 29(34):10627–10637. https://doi.org/10.1523/JNEUROSCI.0620-09.2009
Ovsepian SV, Antyborzec I, O'Leary VB, Zaborszky L, Herms J, Oliver Dolly J (2014) Neurotrophin receptor p75 mediates the uptake of the amyloid beta (Aβ) peptide, guiding it to lysosomes for degradation in basal forebrain cholinergic neurons. Brain Struct Funct 219(5):1527–1541. https://doi.org/10.1007/s00429-013-0583-x
Ovsepian SV, Herms J (2013) Drain of the brain: low-affinity p75 neurotrophin receptor affords a molecular sink for clearance of cortical amyloid β by the cholinergic modulator system. Neurobiol Aging 34(11):2517–2524. https://doi.org/10.1016/j.neurobiolaging.2013.05.005
Ibanez CF, Simi A (2012) p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity. Trends Neurosci 35(7):431–440. https://doi.org/10.1016/j.tins.2012.03.007
Dechant G, Barde YA (2002) The neurotrophin receptor p75NTR: novel functions and implications for diseases of the nervous system. Nat Neurosci 5(11):1131–1136
Coulson EJ, May LM, Sykes AM, Hamlin AS (2009) The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease. Neuroscientist 15(4):317–323. https://doi.org/10.1177/1073858408331376
Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE, Gilchrest BA (1997) Binding of β-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer’s disease. J Clin Invest 100(9):2333–2340
Yaar M, Zhai S, Fine RE, Eisenhauer PB, Arble BL, Stewart KB, Gilchrest BA (2002) Amyloid β binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem 277(10):7720–7725
Wang YR, Wang J, Liu YH, Hu GL, Gao CY, Wang YJ, Zhou XF, Zeng F (2018) Cysteine-rich repeat domains 2 and 4 are amyloid-β binding domains of neurotrophin receptor p75NTR and potential targets to block amyloid-β neurotoxicity. J Alzheimers Dis 63(1):139–147. https://doi.org/10.3233/JAD-171012
Rabizadeh S, Bitler CM, Butcher LL, Bredesen DE (1994) Expression of the low-affinity nerve growth factor receptor enhances β-amyloid peptide toxicity. Proc Natl Acad Sci U S A 91(22):10703–10706
May LM, Anggono V, Gooch HM, Jang SE, Matusica D, Kerbler GM, Meunier FA, Sah P et al (2017) G-protein-coupled inwardly rectifying potassium (GIRK) channel activation by the p75 neurotrophin receptor is required for amyloid β toxicity. Front Neurosci 11:455. https://doi.org/10.3389/fnins.2017.00455
Yang T, Knowles JK, Lu Q, Zhang H, Arancio O, Moore LA, Chang T, Wang Q et al (2008) Small molecule, non-peptide p75 ligands inhibit Aβ-induced neurodegeneration and synaptic impairment. PLoS One 3(11):e3604. https://doi.org/10.1371/journal.pone.0003604
Costantini C, Rossi F, Formaggio E, Bernardoni R, Cecconi D, Della-Bianca V (2005) Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in β-amyloid peptide-dependent cell death. J Mol Neurosci 25(2):141–156
Kuner P, Schubenel R, Hertel C (1998) β-amyloid binds to p75NTR and activates NFκB in human neuroblastoma cells. J Neurosci Res 54(6):798–804
Hu Y, Lee X, Shao Z, Apicco D, Huang G, Gong BJ, Pepinsky RB, Mi S (2013) A DR6/p75NTR complex is responsible for β-amyloid-induced cortical neuron death. Cell Death Dis 4:e579. https://doi.org/10.1038/cddis.2013.110
Wang YJ, Wang X, Lu JJ, Li QX, Gao CY, Liu XH, Sun Y, Yang M et al (2011) p75NTR regulates Aβ deposition by increasing Aβ production but inhibiting Aβ aggregation with its extracellular domain. J Neurosci 31(6):2292–2304. https://doi.org/10.1523/JNEUROSCI.2733-10.2011
Nguyen TV, Shen L, Vander Griend L, Quach LN, Belichenko NP, Saw N, Yang T, Shamloo M et al (2014) Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice. J Alzheimers Dis 42(2):459–483. https://doi.org/10.3233/JAD-140036
Murphy M, Wilson YM, Vargas E, Munro KM, Smith B, Huang A, Li QX, Xiao J et al (2015) Reduction of p75 neurotrophin receptor ameliorates the cognitive deficits in a model of Alzheimer’s disease. Neurobiol Aging 36(2):740–752. https://doi.org/10.1016/j.neurobiolaging.2014.09.014
Jian C, Zou D, Luo C, Liu X, Meng L, Huang J, Li X, Huang R et al (2016) Cognitive deficits are ameliorated by reduction in amyloid β accumulation in Tg2576/p75NTR+/− mice. Life Sci 155:167–173. https://doi.org/10.1016/j.lfs.2016.05.011
Boskovic Z, Alfonsi F, Rumballe BA, Fonseka S, Windels F, Coulson EJ (2014) The role of p75NTR in cholinergic basal forebrain structure and function. J Neurosci 34(39):13033–13038. https://doi.org/10.1523/JNEUROSCI.2364-14.2014
Hamlin AS, Windels F, Boskovic Z, Sah P, Coulson EJ (2013) Lesions of the basal forebrain cholinergic system in mice disrupt idiothetic navigation. PLoS One 8(1):e53472. https://doi.org/10.1371/journal.pone.0053472
Greferath U, Bennie A, Kourakis A, Bartlett PF, Murphy M, Barrett GL (2000) Enlarged cholinergic forebrain neurons and improved spatial learning in p75 knockout mice. Eur J Neurosci 12(3):885–893
Longo FM, Massa SM (2013) Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease. Nat Rev Drug Discov 12(7):507–525
Zeng F, Lu JJ, Zhou XF, Wang YJ (2011) Roles of p75NTR in the pathogenesis of Alzheimer’s disease: a novel therapeutic target. Biochem Pharmacol 82(10):1500–1509. https://doi.org/10.1016/j.bcp.2011.06.040
Mufson EJ, Counts SE, Perez SE, Ginsberg SD (2008) Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications. Expert Rev Neurother 8(11):1703–1718. https://doi.org/10.1586/14737175.8.11.1703
Shepheard SR, Wuu J, Cardoso M, Wiklendt L, Dinning PG, Chataway T, Schultz D, Benatar M et al (2017) Urinary p75ECD: a prognostic, disease progression, and pharmacodynamic biomarker in ALS. Neurology 88(12):1137–1143. https://doi.org/10.1212/WNL.0000000000003741
Jiao SS, Bu XL, Liu YH, Wang QH, Liu CH, Yao XQ, Zhou XF, Wang YJ (2015) Differential levels of p75NTR ectodomain in CSF and blood in patients with Alzheimer’s disease: a novel diagnostic marker. Transl Psychiatry 5:e650. https://doi.org/10.1038/tp.2015.146
Zhou XF, Wang YJ (2011) The p75NTR extracellular domain: a potential molecule regulating the solubility and removal of amyloid-β. Prion 5(3):161–163
Wang QH, Wang YR, Zhang T, Jiao SS, Liu YH, Zeng F, Li J, Yao XQ et al (2016) Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer’s disease-like pathologies in APP/PS1 transgenic mice. J Neurochem 138(1):163–173. https://doi.org/10.1111/jnc.13616
Yao XQ, Jiao SS, Saadipour K, Zeng F, Wang QH, Zhu C, Shen LL, Zeng GH et al (2015) p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-β toxicity in the brain of Alzheimer’s disease. Mol Psychiatry 20(11):1301–1310. https://doi.org/10.1038/mp.2015.49
Cimadevilla JM, Kaminsky Y, Fenton A, Bures J (2000) Passive and active place avoidance as a tool of spatial memory research in rats. J Neurosci Meth 102(2):155–164
Wesierska M, Dockery C, Fenton AA (2005) Beyond memory, navigation, and inhibition: behavioral evidence for hippocampus-dependent cognitive coordination in the rat. J Neurosci 25(9):2413–2419. https://doi.org/10.1523/JNEUROSCI.3962-04.2005
Shepheard SR, Chataway T, Schultz DW, Rush RA, Rogers ML (2014) The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis. PLoS One 9(1):e87398. https://doi.org/10.1371/journal.pone.0087398
Matusica D, Alfonsi F, Turner BJ, Butler TJ, Shepheard SR, Rogers ML, Skeldal S, Underwood CK et al (2016) Inhibition of motor neuron death in vitro and in vivo by a p75 neurotrophin receptor intracellular domain fragment. J Cell Sci 129(3):517–530. https://doi.org/10.1242/jcs.173864
Vukovic J, Borlikova GG, Ruitenberg MJ, Robinson GJ, Sullivan RK, Walker TL, Bartlett PF (2013) Immature doublecortin-positive hippocampal neurons are important for learning but not for remembering. J Neurosci 33(15):6603–6613. https://doi.org/10.1523/JNEUROSCI.3064-12.2013
Mufson EJ, Kordower JH (1992) Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease. Proc Natl Acad Sci U S A 89(2):569–573
Chakravarthy B, Gaudet C, Menard M, Atkinson T, Brown L, Laferla FM, Armato U, Whitfield J (2010) Amyloid-β peptides stimulate the expression of the p75NTR neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. J Alz Dis 19(3):915–925. https://doi.org/10.3233/JAD-2010-1288
Perini G, Della-Bianca V, Politi V, Della Valle G, Dal-Pra I, Rossi F, Armato U (2002) Role of p75 neurotrophin receptor in the neurotoxicity by β-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med 195(7):907–918
Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ (2001) Neuropathology of mice carrying mutant APPswe and/or PS1M146L transgenes: alterations in the p75NTR cholinergic basal forebrain septohippocampal pathway. Exp Neurol 170(2):227–243
Catts VS, Al-Menhali N, Burne TH, Colditz MJ, Coulson EJ (2008) The p75 neurotrophin receptor regulates hippocampal neurogenesis and related behaviours. Eur J Neurosci 28(5):883–892. https://doi.org/10.1111/j.1460-9568.2008.06390.x
Boskovic Z, Milne M, Qian L, Clifton H, McGovern AE, Turnbull MT, Mazzone SB, Coulson EJ (2018) Cholinergic basal forebrain neurons regulate fear extinction consolidation through p75 neurotrophin receptor signaling. Transl Psychiatry 8:199. https://doi.org/10.1038/s41398-018-0248-x, https://www.nature.com/articles/s41398-018-0248-x
Rosch H, Schweigreiter R, Bonhoeffer T, Barde YA, Korte M (2005) The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus. Proc Natl Acad Sci U S A 102(20):7362–7367
Woo NH, Teng HK, Siao CJ, Chiaruttini C, Pang PT, Milner TA, Hempstead BL, Lu B (2005) Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 8(8):1069–1077
Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D et al (2000) High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20(11):4050–4058
Agholme L, Hallbeck M (2014) Getting rid of intracellular Aβ - loss of cellular degradation leads to transfer between connected neurons. Curr Pharm Des 20(15):2458–2468
Zuroff L, Daley D, Black KL, Koronyo-Hamaoui M (2017) Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes. Cell Mol Life Sci 74(12):2167–2201. https://doi.org/10.1007/s00018-017-2463-7
Solito E, Sastre M (2012) Microglia function in Alzheimer’s disease. Front Pharmacol 3:14. https://doi.org/10.3389/fphar.2012.00014
Caccamo A, Oddo S, Billings LM, Green KN, Martinez-Coria H, Fisher A, LaFerla FM (2006) M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49(5):671–682. https://doi.org/10.1016/j.neuron.2006.01.020
Davis AA, Fritz JJ, Wess J, Lah JJ, Levey AI (2010) Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo. J Neurosci 30(12):4190–4196. https://doi.org/10.1523/JNEUROSCI.6393-09.2010
Kolisnyk B, Al-Onaizi MA, Xu J, Parfitt GM, Ostapchenko VG, Hanin G, Soreq H, Prado MA et al (2016) Cholinergic regulation of hnRNPA2/B1 translation by M1 muscarinic receptors. J Neurosci 36(23):6287–6296. https://doi.org/10.1523/JNEUROSCI.4614-15.2016
Kolisnyk B, Al-Onaizi M, Soreq L, Barbash S, Bekenstein U, Haberman N, Hanin G, Kish MT et al (2017) Cholinergic surveillance over hippocampal RNA metabolism and Alzheimer’s-like pathology. Cereb Cortex 27(7):3553–3567. https://doi.org/10.1093/cercor/bhw177
Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 4(147):147ra111. https://doi.org/10.1126/scitranslmed.3003748
Peng W, Achariyar TM, Li B, Liao Y, Mestre H, Hitomi E, Regan S, Kasper T et al (2016) Suppression of glymphatic fluid transport in a mouse model of Alzheimer’s disease. Neurobiol Dis 93:215–225. https://doi.org/10.1016/j.nbd.2016.05.015
Hamner JW, Tan CO, Tzeng YC, Taylor JA (2012) Cholinergic control of the cerebral vasculature in humans. J Physiol 590(24):6343–6352. https://doi.org/10.1113/jphysiol.2012.245100
Liu Y, Studzinski C, Beckett T, Murphy MP, Klein RL, Hersh LB (2010) Circulating neprilysin clears brain amyloid. Mol Cell Neurosci 45(2):101–107. https://doi.org/10.1016/j.mcn.2010.05.014
Acknowledgements
We thank other members of our laboratories, particularly Bree Rumballe (Coulson Lab) and Micell Cardoso (Rogers Lab) for administrative and technical assistance respectively, as well as helpful discussions, Luke Hammond for assistance with microscopy analysis and Rowan Tweedale for critical reading and editing of the manuscript.
Funding
This work was supported by the Australian National Health and Medical Research Council of Australia [project grant 1049236 to EJC; project grant 1139469 and Boosting Dementia Fellowship 1139469 to RM], and a Motor Neuron Disease Australia Grant in Aid [MLR,SS].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures were approved by the University of Queensland Animal Ethics Committee and conducted in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.
Conflict of Interest
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Qian, L., Milne, M.R., Shepheard, S. et al. Removal of p75 Neurotrophin Receptor Expression from Cholinergic Basal Forebrain Neurons Reduces Amyloid-β Plaque Deposition and Cognitive Impairment in Aged APP/PS1 Mice. Mol Neurobiol 56, 4639–4652 (2019). https://doi.org/10.1007/s12035-018-1404-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-018-1404-2